These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3082957)

  • 21. Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardia.
    Bleske BE; Kluger J; Fisher J; Chow MS
    J Clin Pharmacol; 1989 Nov; 29(11):998-1002. PubMed ID: 2513339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry.
    Miles WM; Chang MS; Heger JJ; Rinkenberger RL; Zipes DP; Prystowsky EN
    Am Heart J; 1987 Jul; 114(1 Pt 1):26-33. PubMed ID: 3111237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encainide for treatment of supraventricular tachycardias associated with the Wolff-Parkinson-White syndrome.
    Markel ML; Prystowsky EN; Heger JJ; Miles WM; Fineberg N; Zipes DP
    Am J Cardiol; 1986 Aug; 58(5):41C-48C. PubMed ID: 3092619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
    Roden DM; Reele SB; Higgins SB; Mayol RF; Gammans RE; Oates JA; Woosley RL
    N Engl J Med; 1980 Apr; 302(16):877-82. PubMed ID: 6767186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction. The Encainide-Ventricular Tachycardia Study Group.
    Am J Cardiol; 1988 Sep; 62(9):571-5. PubMed ID: 3137797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
    Thale J; Klein H; Shanks RG; Bender F
    Z Kardiol; 1985 Apr; 74(4):220-7. PubMed ID: 2408392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Encainide and flecainide: are they interchangeable?
    Saini V; Podrid PJ; Slater W; Lown B
    Am Heart J; 1989 Jun; 117(6):1253-8. PubMed ID: 2499169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptoms.
    Horowitz LN
    Am J Cardiol; 1986 Aug; 58(5):83C-86C. PubMed ID: 3092624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation.
    Berns E; Rinkenberger RL; Jeang MK; Dougherty AH; Jenkins M; Naccarelli GV
    Am J Cardiol; 1987 Jun; 59(15):1337-41. PubMed ID: 3109229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New directions in antiarrhythmic drug therapy.
    Somberg JC
    Am J Cardiol; 1984 Aug; 54(4):8B-17B. PubMed ID: 6147082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole].
    Dumoulin P; Jaillon P; Kher A; Poirier JM; Cheymol G; Valty J; Flammang D; Coumel P; Medvedowsky JL; Barnay C
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():105-9. PubMed ID: 2420299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encainide for refractory supraventricular tachycardia in children.
    Strasburger JF; Moak JP; Smith RT; McVey-Duncan P; Armstrong K; Garson A
    Am J Cardiol; 1986 Aug; 58(5):49C-54C. PubMed ID: 3092620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) Investigators
    Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
    Echt DS; Liebson PR; Mitchell LB; Peters RW; Obias-Manno D; Barker AH; Arensberg D; Baker A; Friedman L; Greene HL
    N Engl J Med; 1991 Mar; 324(12):781-8. PubMed ID: 1900101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of ventricular arrhythmias in children without structural heart disease with class IC agents as guided by invasive electrophysiology.
    Case CL; Gillette PC
    Am J Cardiol; 1990 Nov; 66(17):1265-6. PubMed ID: 2122708
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.
    Pritchett EL; Wilkinson WE
    Am J Cardiol; 1991 May; 67(11):976-80. PubMed ID: 1902055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
    Niazi I; Naccarelli G; Dougherty A; Rinkenberger R; Tchou P; Akhtar M
    J Am Coll Cardiol; 1989 Mar; 13(4):904-10. PubMed ID: 2494243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.